Zakrzewski Joseph S

CIK 00013318528 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001331852

Recent Transactions

50 trades

Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2026-02-20+20,400→ 20,400 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2025-05-22+19,111→ 19,111 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-04-10+10,523→ 145,538 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-12-19+9,816→ 135,015 total
Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-11-27$1.40/sh+2,000→ 125,199 total
Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-11-19$1.01/sh+5,000→ 123,199 total
Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-11-18$1.00/sh+20,000→ 118,199 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2024-06-19+64,503→ 64,503 total
Exercise/Conversion
Cyteir Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-06−14,150→ 0 total
Exercise/Conversion
Cyteir Therapeutics, Inc.
Common Stock
2024-02-06$1.69/sh+14,150→ 227,439 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-18$19.11/sh−100,000→ 405,880 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-06-07+23,742→ 23,742 total
Award
Cyteir Therapeutics, Inc.
Stock Option (Right to Buy)
2023-02-03+14,150→ 14,150 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2022-12-07$1.30/sh+21,202→ 154,618 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+10,362→ 10,362 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2022-05-12$1.61/sh+743→ 133,416 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2022-05-11$1.70/sh+1,000→ 132,673 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2022-05-10$1.89/sh+49,406→ 131,673 total
Conversion
AN2 Therapeutics, Inc.$ANTX
Series A Convertible Preferred Stock
2022-03-29−98,199→ 0 total
Conversion
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-03-29+98,199→ 98,199 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2022-02-25+25,000→ 25,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2022-02-25+12,500→ 60,700 total
Award
Cyteir Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-22+14,150→ 14,150 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-28$9.85/sh+601→ 82,267 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-27$10.18/sh+99→ 81,666 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-27$9.97/sh+200→ 81,567 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-23$9.87/sh+200→ 81,367 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-17$9.88/sh+200→ 81,167 total
Purchase
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2021-12-15$3.15/sh+2,000→ 196,547 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-15$11.12/sh+1,700→ 80,967 total
Purchase
Cyteir Therapeutics, Inc.
Common Stock
2021-12-15$10.47/sh+2,000→ 79,267 total
Purchase
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2021-12-14$3.27/sh+10,000→ 194,547 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−7,500→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−3,222→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−7,500→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−10,000→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−10,000→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−8,185→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−7,500→ 0 total
Disposition from Tender
ACCELERON PHARMA INC
Common Stock
2021-11-19−34,499→ 0 total
Conversion
Cyteir Therapeutics, Inc.
Common Stock
2021-06-22+58,671→ 58,671 total
Conversion
Cyteir Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-06-22−200,000→ 0 total
Award
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2021-06-14+45,953→ 45,953 total
Award
AMARIN CORP PLC\UK$AMRN
Restricted Stock Units
2021-06-14+36,000→ 36,000 total
Sale
ACCELERON PHARMA INC
Common Stock
2021-04-05$141.28/sh−2,152→ 35,599 total
Sale
ACCELERON PHARMA INC
Common Stock
2021-04-05$140.31/sh−6,748→ 37,751 total
Exercise/Conversion
ACCELERON PHARMA INC
Common Stock
2021-04-05$24.11/sh+10,000→ 44,499 total
Exercise/Conversion
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-04-05−10,000→ 0 total
Sale
ACCELERON PHARMA INC
Common Stock
2021-04-05$142.27/sh−1,100→ 34,499 total
Exercise/Conversion
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-04-01−10,000→ 10,000 total

Companies

Recent Filings

Address

C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov